Inari Medical Inc

Inari Medical Inc(NARI)の株式分析

$79.970

+0.040 (+0.05%)終値時点

Loading chart…
高値
79.990
始値
79.970
出来高加重平均価格
79.97
出来高
2.36M
時価総額
2.73B
安値
79.960
売買代金
188.66M
EV/EBITDA(TTM)
243.88

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

www.inarimedical.com

バリュエーション指標

Inari Medical Inc(NARI)の現在の予想PERは305.46で、5年平均は6.05です。

予想PER

適正
5年平均 P/E
6.05
現在のP/E
305.46
割高
460.93
割安
-448.82

予想EV/EBITDA

適正
5年平均 EV/EBITDA
356.73
現在のEV/EBITDA
243.88
割高
1726.33
割安
-1012.88

予想PSR

適正
5年平均 P/S
7.35
現在のP/S
6.60
割高
10.08
割安
4.63

NARI のよくある質問 — Alphio AI が回答

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める